Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00049257 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: carboplatin
DRUG: paclitaxel

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]